# Abaloparatide (Tymlos)

Source: https://ourhealthnetwork.com/drugs/abaloparatide
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Abaloparatide?

Abaloparatide (brand name: Tymlos) is a parathyroid hormone-related peptide analog. It is prescribed to treat osteoporosis, postmenopausal. Across the United States, 2,000 doctors prescribe Abaloparatide to approximately 3,000 Medicare patients.

## Brand names

Tymlos

## Indications

Abaloparatide is prescribed for the treatment of osteoporosis and postmenopausal.

## Conditions treated

- [Osteoporosis](https://ourhealthnetwork.com/conditions/osteoporosis)
- [Postmenopausal](https://ourhealthnetwork.com/conditions/postmenopausal)

## Mechanism of action

Abaloparatide is a PTHrP(1-34) analog which acts as an agonist at the PTH1 receptor (PTH1R). This results in activation of the cAMP signaling pathway in target cells.

## Drug classification

- Established Pharmacologic Class: Parathyroid Hormone-Related Peptide Analog [EPC]
- Route of administration: SUBCUTANEOUS

## Common side effects

and palpitations, dizziness, fatigue, headache, hypercalciuria, nausea, palpitations, s group were nausea

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)